Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
European Heart Journal
|
April 9, 2024
Infection, inflammation, and cardiovascular risk: are we underestimating an old disease?
Natalie Arnold, Wolfgang Koenig
Current Opinion in Lipidology
|
October 3, 2019
Is proteomics of value in cardiovascular risk assessment?
Natalie Arnold, Wolfgang Koenig
Deutsche Medizinische Wochenschrift (1946)
|
March 6, 2019
[Atherosclerosis as an Inflammatory Disease - Pathophysiology, Clinical Relevance and Therapeutic Implications]
Natalie Arnold, Wolfgang Koenig
European Heart Journal
|
August 29, 2025
Quiet Flames: Inflammation Without Traditional Risk Factors
Natalie Arnold, Wolfgang Koenig
Cardiovascular Drugs and Therapy
|
November 6, 2020
Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Natalie Arnold, Wolfgang Koenig
Current Cardiology Reports
|
September 10, 2022
PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection
Natalie Arnold, Wolfgang Koenig
European Journal of Clinical Investigation
|
March 8, 2025
Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment
Natalie Arnold, Wolfgang Koenig
Reviews in Cardiovascular Medicine
|
July 30, 2024
Familial Hypercholesterolemia: Pitfalls and Challenges in Diagnosis and Treatment
Natalie Arnold, Wolfgang Koenig
Current Atherosclerosis Reports
|
November 28, 2023
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
Natalie Arnold, Wolfgang Koenig
Cardiovascular Drugs and Therapy
|
September 28, 2024
Correction to: Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Natalie Arnold, Wolfgang Koenig
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
European Heart Journal
|
April 9, 2024
Infection, inflammation, and cardiovascular risk: are we underestimating an old disease?
Natalie Arnold, Wolfgang Koenig
Current Opinion in Lipidology
|
October 3, 2019
Is proteomics of value in cardiovascular risk assessment?
Natalie Arnold, Wolfgang Koenig
Deutsche Medizinische Wochenschrift (1946)
|
March 6, 2019
[Atherosclerosis as an Inflammatory Disease - Pathophysiology, Clinical Relevance and Therapeutic Implications]
Natalie Arnold, Wolfgang Koenig
European Heart Journal
|
August 29, 2025
Quiet Flames: Inflammation Without Traditional Risk Factors
Natalie Arnold, Wolfgang Koenig
Cardiovascular Drugs and Therapy
|
November 6, 2020
Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Natalie Arnold, Wolfgang Koenig
Current Cardiology Reports
|
September 10, 2022
PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection
Natalie Arnold, Wolfgang Koenig
European Journal of Clinical Investigation
|
March 8, 2025
Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment
Natalie Arnold, Wolfgang Koenig
Reviews in Cardiovascular Medicine
|
July 30, 2024
Familial Hypercholesterolemia: Pitfalls and Challenges in Diagnosis and Treatment
Natalie Arnold, Wolfgang Koenig
Current Atherosclerosis Reports
|
November 28, 2023
Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
Natalie Arnold, Wolfgang Koenig
Cardiovascular Drugs and Therapy
|
September 28, 2024
Correction to: Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
Natalie Arnold, Wolfgang Koenig
Page
of 7